武汉科斯坦生物科技有限公司
服务热线:15926423062
产品展厅
Recombinant Human FPR1 protein
  • 品牌:chemstan
  • 产地:中国
  • 货号:CSP02002
  • 价格: ¥1280/支
  • 发布日期: 2020-11-03
  • 更新日期: 2025-06-18
产品详请
产地 中国
品牌 chemstan
货号 CSP02002
用途 科研实验
包装规格 50ug
纯度 >90%
CAS编号
是否进口

概述(Summary)icon

                                                   

英文全称

Recombinant Human FPR1 protein

纯度(Purity)

>90% as determined by SDS-PAGE

内毒素(Endotoxin level)

Please contact with the lab for this information.

蛋白构建(Construction)

A DNA sequence encoding the human FPR1 (Arg163-Val242) was fused with GST tag

Accession #

P21462

表达宿主(Host)

E.coli

种属(Species)

Homo sapiens (Human)

预测分子量(Predicted Molecular Mass)

33.52 kDa

制剂(Formulation)

Supplied as solution form  in  PBS pH 7.5./ Lyophilized from PBS pH 7.5.

运输方式(Shipping)

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

稳定性&储存(Stability &Storage)

Use a manual defrost freezer and avoid repeated freeze thaw cycles.
Store at 2 to 8 °C for one week .
Store at -20 to -80 °C for twelve months from the date of receipt.

复溶(Reconstitution)

Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.

                                                   

背景(Background)icon

                                                   

背景介绍

High affinity receptor for N-formyl-methionyl peptides (fMLP), which are powerful neutrophil chemotactic factors . Binding of fMLP to the receptor stimulates intracellular calcium mobilization and superoxide anion release. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. Receptor for TAFA4, mediates its effects on chemoattracting macrophages, promoting phagocytosis and increasing ROS release.

分子别名(Alternative Names)

fMet-Leu-Phe receptor,fMLP receptor,N-formyl peptide receptor,FPR,N-formylpeptide chemoattractant receptor.


联系方式
手机:15926423062
手机访问官网